Bold

Presentation

The Bold T20 Ventilator was developed following the MHRA (Medicines and Healthcare products Regulatory Agency - UK) guidelines, for use in cases of mass casualties and low resource environments.

It Works in Continuous Mandatory Ventilation (CMV) mode, by Volume Controlled Ventilation (VCV) providing assured tidal volume and respiratory rate controlled modes allowing it to be used widely in emergency medicine, primary and mass care, health units and patient transport with respiratory failure.

It is safely equippeded with alarms such as Low Battery, Battery failure, Low pressure, Airway pressure exceeded, Breathing circuit disconneciton, all Monitoring and Alarms in Compliance to ABNT NBR IEC 60601-1-8:2020, ISO 9703-1, ABNT NBR ISO 10651-3:2014. With intuitive adjustable display.

Built in a simple design with a LCD display it provides an intuitive interface. It has a long-life rechargeable internal battery (>4h autonomy). It is a light equipment (12kg) which facilitates its transportation with practical handle.

Manufactured in a Safe and reliable way, using high strenght material, and last but not least, most of them are all National material with vast availability in the market, enabling a large scale of it.

Adjustable and easy-to-read inspiratory volume, ranging from 200 to 500mL, depending on the patient's need and weight, regardless of respiratory rate, allowing the device to be used on adults and children. In addition, the relationship between inspiration and exhalation (I: E) can be adjusted quickly, as needed.

It is featured with Respiratory Rate (RR) which allows a range from bradypnea to tachpnea

With a tidal volume (TV) adjustable between range of 50 -700 mL easy to read through the LCD display, it can be set depending on the patient's needs, furthermore, the I:E provides adjustable Inspiratory: Expiratory ratio with the range of 1:1 – 1:3

Request a Cotation
Bold

T20

Productive capacity: 400 units / day of T20 lung ventilators, which can be purchased immediately for immediate application to combat the pandemic of COVID-19, after ANVISA's release for this purpose.

The upper pressure, which will initially be limited by an alarm and, after a certain pressure level, will stop its operation recognizing that the patient is starting to breathe on his own, allowing ventilatory disarming from spontaneous ventilation.

It allows controlling the inspiratory and expiratory ratios from 1: 1 to 1: 3. Changes in respiratory rate can also be controlled, ranging from 10 to 60 breaths per minute. This makes it possible to use it both in a patient who is completely sedated, maintaining volume-controlled breathing, and in a patient who eventually has a respiratory response, automatically recognizing and interrupting its functioning, allowing the patient's own ventilation.

Request a Cotation